U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
127321127321Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)CompletedHas ResultsType 2 Diabetes MellitusDrug: Saxagliptin|Drug: Metformin IR (glucophage)|Drug: Saxagliptin + Metformin IR (FDC)https://ClinicalTrials.gov/show/NCT00897390
127322127322Treatment Strategy for Low-grade GliomasTerminatedNo Results AvailableAstrocytomas|Oligodendrogliomas|OligoastrocytomaRadiation: Radiation therapy|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00897377
127323127323Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-SmokersActive, not recruitingNo Results AvailableLung Cancer|Precancerous ConditionOther: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897364
127324127324Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803Not yet recruitingNo Results AvailableProstate CancerGenetic: mutation analysis|Genetic: polymorphism analysis|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897351
127325127325Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast CancerCompletedNo Results AvailableBreast CancerOther: flow cytometry|Other: fluorescence activated cell sorting|Other: immunohistochemistry staining method|Other: immunologic technique|Other: biomarker analysishttps://ClinicalTrials.gov/show/NCT00897338
127326127326Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaRecruitingNo Results AvailableLeukemia|LymphomaOther: biologic sample preservation procedurehttps://ClinicalTrials.gov/show/NCT00897325
127327127327Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn DiseaseCompletedNo Results AvailableMelanomaBiological: infliximab|Biological: pegylated interferon alfa|Biological: ticilimumab|Drug: ribavirin|Other: high performance liquid chromatography|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897312
127328127328Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With ChemotherapyCompletedNo Results AvailableBreast Cancer|Estrogen Receptor|Her-2|PgrGenetic: microarray analysis|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897299
127329127329Study of Stored Tumor Samples in Young Patients With Brain TumorsRecruitingNo Results AvailableBrain and Central Nervous System Tumorshttps://ClinicalTrials.gov/show/NCT00897286
127330127330Human Papillomavirus Infection of the Mouth in Young Men and Risk Factors for Oropharyngeal CancerCompletedNo Results AvailableHead and Neck Cancer|Infection|Precancerous ConditionGenetic: comparative genomic hybridization|Genetic: gene expression analysis|Other: study of socioeconomic and demographic variables|Procedure: evaluation of cancer risk factors|Procedure: study of high risk factorshttps://ClinicalTrials.gov/show/NCT00897273
127331127331Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic DisordersRecruitingNo Results AvailableHematological Malignancy|Bone Marrow Failure SyndromeDrug: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders|Radiation: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders|Procedure: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disordershttps://ClinicalTrials.gov/show/NCT00897260
127332127332Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteCompletedNo Results AvailableMalignant Mesothelioma|Pulmonary ComplicationsGenetic: microarray analysis|Genetic: protein expression analysis|Genetic: proteomic profiling|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897247
127333127333Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy VolunteersCompletedNo Results AvailableLung CancerOther: Mass Spectrometryhttps://ClinicalTrials.gov/show/NCT00897234
127334127334A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's AtaxiaCompletedNo Results AvailableFriedreich's AtaxiaDrug: Deferiprone oral solution 100mg/mL|Drug: Deferiprone oral solution 100 mg/mLhttps://ClinicalTrials.gov/show/NCT00897221
127335127335Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast CancerActive, not recruitingNo Results AvailableBreast CancerOther: high performance liquid chromatography|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: medical chart review|Procedure: evaluation of cancer risk factorshttps://ClinicalTrials.gov/show/NCT00897208
127336127336Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid LeukemiaWithdrawnNo Results AvailableLeukemiaGenetic: microarray analysis|Genetic: polymerase chain reactionhttps://ClinicalTrials.gov/show/NCT00897182
127337127337A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese SubjectsCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Other: Oral Glucose Tolerance Test (OGTT)|Other: Euglycaemic hyperinsulinaemic clamphttps://ClinicalTrials.gov/show/NCT00897169
127338127338Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung CancerWithdrawnNo Results AvailableLung Cancer|Metastatic CancerGenetic: microarray analysis|Genetic: mutation analysis|Other: flow cytometry|Other: immunologic techniquehttps://ClinicalTrials.gov/show/NCT00897143
1273391273395-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)CompletedNo Results AvailableMyelodysplastic SyndromeDrug: Azacytidinehttps://ClinicalTrials.gov/show/NCT00897130
127340127340Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerRecruitingNo Results AvailableLung CancerGenetic: gene expression analysis|Genetic: microarray analysis|Genetic: protein expression analysis|Other: biologic sample preservation procedure|Other: laboratory biomarker analysis|Other: matrix-assisted laser desorption/ionization time of flight mass spectrometryhttps://ClinicalTrials.gov/show/NCT00897117
127341127341MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)CompletedHas ResultsMigraine HeadacheDrug: rizatriptan benzoate (MK0462)|Drug: Comparator: sumatriptan|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00897104
127342127342S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and FluorouracilCompletedNo Results AvailableBreast CancerGenetic: comparative genomic hybridization|Genetic: microarray analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897091
127343127343Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy SiblingsCompletedNo Results AvailableLeukemiaOther: laboratory biomarker analysis|Other: medical chart review|Other: metabolic assessment|Other: questionnaire administration|Procedure: assessment of therapy complicationshttps://ClinicalTrials.gov/show/NCT00897078
127344127344Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17RecruitingNo Results AvailableBreast CancerGenetic: microarray analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis|Other: fluorescent antibody technique|Other: immunohistochemistry staining method|Other: immunologic techniquehttps://ClinicalTrials.gov/show/NCT00897065
127345127345Gene Expression Profiles in Predicting Survival of Patients With Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerGenetic: microarray analysis|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00897052
127346127346Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerRecruitingNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerOther: flow cytometry|Other: immunohistochemistry staining methodhttps://ClinicalTrials.gov/show/NCT00897039
127347127347Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344RecruitingNo Results AvailableBreast CancerDrug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Genetic: fluorescence in situ hybridization|Other: immunohistochemistry staining methodhttps://ClinicalTrials.gov/show/NCT00897026
127348127348Lamotrigine Cognitive Function Study in Adult Untreated EpilepsiesCompletedNo Results AvailableEpilepsyDrug: lamotrigine (Lamictal)|Drug: Carbamazepine (Tegretol)https://ClinicalTrials.gov/show/NCT00896987
127349127349Study of 9cUAB30 in Healthy ParticipantsCompletedNo Results AvailableNo Evidence of DiseaseOther: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Retinoid 9cUAB30https://ClinicalTrials.gov/show/NCT00896974
127350127350EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerTerminatedNo Results AvailableStage I Adult Soft Tissue Sarcoma|Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage II Adult Soft Tissue Sarcoma|Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Adult Soft Tissue Sarcoma|Stage III Squamous Cell CarcinoDrug: EF5|Other: diagnostic laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00896961

* Görseller ve İçerik tekif hakkına sahip olabilir